Variables | Group A (n = 40) | Group B (n = 40) | Group C (n = 39) | P values* |
---|---|---|---|---|
Resting VAS | ||||
2 h | 2.4 ± 0.7 | 2.3 ± 0.9 | 3.4 ± 1.0 | < 0.001** |
6 h | 2.3 ± 0.6 | 2.1 ± 0.6 | 2.9 ± 0.7 | < 0.001** |
12 h | 2.2 ± 0.8 | 2.0 ± 0.5 | 2.6 ± 0.8 | 0.002** |
24 h | 1.8 ± 0.4 | 1.8 ± 0.6 | 1.8 ± 0.5 | 0.834 |
36 h | 1.7 ± 0.6 | 1.6 ± 0.6 | 1.6 ± 0.6 | 0.850 |
48 h | 1.2 ± 0.4 | 1.2 ± 0.4 | 1.3 ± 0.6 | 0.268 |
60 h# | 1.1 ± 0.3 | 1.1 ± 0.3 | 1.3 ± 0.5 | 0.153 |
72 h# | 1.1 ± 0.3 | 1.0 ± 0.2 | 1.2 ± 0.4 | 0.122 |
Movement VAS | ||||
6 h | 3.8 ± 0.7 | 3.7 ± 0.9 | 4.6 ± 0.8 | < 0.001** |
12 h | 3.7 ± 0.8 | 3.5 ± 0.6 | 4.2 ± 0.9 | < 0.001** |
24 h | 3.3 ± 0.5 | 3.2 ± 0.5 | 3.4 ± 0.5 | 0.244 |
36 h | 3.2 ± 0.5 | 3.1 ± 0.4 | 3.1 ± 0.5 | 0.474 |
48 h | 2.7 ± 0.6 | 2.8 ± 0.4 | 2.9 ± 0.8 | 0.464 |
60 h# | 2.8 ± 0.6 | 2.6 ± 0.5 | 2.9 ± 0.3 | 0.170 |
72 h# | 2.1 ± 0.3 | 2.2 ± 0.4 | 2.3 ± 0.5 | 0.317 |
Morphine equivalents (mg) | ||||
0-12 h | 2.3 ± 5.4 | 1.9 ± 5.0 | 4.2 ± 7.7 | 0.191 |
0-24 h | 9.1 ± 13.3 | 9.6 ± 14.6 | 11.8 ± 15.7 | 0.688 |
Total during hospitalisation | 32.5 ± 47.2 | 32.1 ± 48.2 | 48.6 ± 57.8 | 0.270 |